Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PF-07248144 |
| Trade Name | |
| Synonyms | PF07248144|PF 07248144 |
| Drug Descriptions |
PF-07248144 selectively inhibits KAT6, a histone acetyltransferase regulating gene expression, which may lead to tumor growth inhibition (J Clin Oncol 41, 2023 (suppl 16; abstr 1054)). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C178474 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Fulvestrant + Palbociclib + PF-07248144 | Fulvestrant PF-07248144 Palbociclib | 0 | 1 |
| Fulvestrant + PF-07220060 + PF-07248144 | Fulvestrant PF-07220060 PF-07248144 | 0 | 1 |
| Fulvestrant + PF-07248144 | Fulvestrant PF-07248144 | 0 | 2 |
| Letrozole + Palbociclib + PF-07248144 | Letrozole PF-07248144 Palbociclib | 0 | 1 |
| PF-07248144 | PF-07248144 | 0 | 1 |
| PF-07248144 + Vepdegestrant | PF-07248144 Vepdegestrant | 0 | 1 |